INTRODUCTION AND OBJECTIVES: Cardiovascular risk screening requires accurate risk functions. The relative validity of the Framingham-based REGICOR adapted function is analyzed and the population distribution of cardiovascular 10-year cardiovascular events is described by risk group. METHODS: A population cohort of 3856 participants recruited between 1995 and 2000, aged 35 to 74 years from Girona without symptoms of cardiovascular diseases, was followed between 2006 and 2009. Standardized laboratory and blood pressure measurements, questionnaires, and case definitions were used. The follow-up combined cross-linkage of our databases with our regional mortality registry, reexamination, and telephone contact with participants. Coronary disease endpoints alone were considered. RESULTS: A total of 27 487 person-years were obtained (mean follow-up 7.1 years), and the follow-up was achieved in 97% of participants (120 coronary disease events). Validity was good: the regression coefficients estimated with the cohort data did not differ from those obtained in the original Framingham function. Function calibration was good: the observed incidence of cardiovascular events in the decile groups of risk did not differ from the function prediction (P=.127 in women, and P=.054 in men). The C statistic (discrimination) was 0.82 (95% confidence interval, 0.76-0.88) in women, and 0.78 (95% confidence interval, 0.73-0.83) in men. More than 50% of cardiovascular events occurred in participants whose 10-year risk was 5% to 14.9%. CONCLUSIONS: The studied function accurately predicts coronary disease events at 10 years. Risk stratification could be simplified in 4 groups: low (<5%), moderate (5%-9.9%), high (10%-14.9%) and very high (≥15%).
INTRODUCTION AND OBJECTIVES: Cardiovascular risk screening requires accurate risk functions. The relative validity of the Framingham-based REGICOR adapted function is analyzed and the population distribution of cardiovascular 10-year cardiovascular events is described by risk group. METHODS: A population cohort of 3856 participants recruited between 1995 and 2000, aged 35 to 74 years from Girona without symptoms of cardiovascular diseases, was followed between 2006 and 2009. Standardized laboratory and blood pressure measurements, questionnaires, and case definitions were used. The follow-up combined cross-linkage of our databases with our regional mortality registry, reexamination, and telephone contact with participants. Coronary disease endpoints alone were considered. RESULTS: A total of 27 487 person-years were obtained (mean follow-up 7.1 years), and the follow-up was achieved in 97% of participants (120 coronary disease events). Validity was good: the regression coefficients estimated with the cohort data did not differ from those obtained in the original Framingham function. Function calibration was good: the observed incidence of cardiovascular events in the decile groups of risk did not differ from the function prediction (P=.127 in women, and P=.054 in men). The C statistic (discrimination) was 0.82 (95% confidence interval, 0.76-0.88) in women, and 0.78 (95% confidence interval, 0.73-0.83) in men. More than 50% of cardiovascular events occurred in participants whose 10-year risk was 5% to 14.9%. CONCLUSIONS: The studied function accurately predicts coronary disease events at 10 years. Risk stratification could be simplified in 4 groups: low (<5%), moderate (5%-9.9%), high (10%-14.9%) and very high (≥15%).
Authors: Alba Sánchez-Viñas; Carmen Corral-Partearroyo; Montserrat Gil-Girbau; M Teresa Peñarrubia-María; Carmen Gallardo-González; María-Del-Carmen Olmos-Palenzuela; Ignacio Aznar-Lou; Antoni Serrano-Blanco; Maria Rubio-Valera Journal: BMC Prim Care Date: 2022-07-05
Authors: Isaac Subirana; Anna Camps-Vilaró; Roberto Elosua; Jaume Marrugat; Helena Tizón-Marcos; Ivan Palomo; Irene R Dégano Journal: Clin Epidemiol Date: 2022-10-11 Impact factor: 5.814
Authors: Luis A Pérula; Josep M Bosch; Julia Bóveda; Manuel Campiñez; Nieves Barragán; Juan C Arboniés; Jose A Prados; Enrique Martín; Remedios Martín; Josep Massons; Margarita Criado; Roger Ruiz; José A Fernández; Francisco Buitrago; Inmaculada Olaya; Modesto Pérez; Joaquin Ruiz Journal: BMC Fam Pract Date: 2011-11-05 Impact factor: 2.497
Authors: A Ramírez de Arellano; A Coca; M de la Figuera; C Rubio-Terrés; D Rubio-Rodríguez; A Gracia; A Boldeanu; J Puig-Gilberte; E Salas Journal: Appl Health Econ Health Policy Date: 2013-10 Impact factor: 2.561
Authors: Rosa Forés; Josep M Manresa; Victor M López-Lifante; Antonio Heras; Pilar Delgado; Xose Vázquez; Susana Ruiz; Maria Teresa Alzamora; Pere Toran Journal: Diagnostics (Basel) Date: 2021-05-24
Authors: Luis Á Pérula; Manuel Campiñez; Josep M Bosch; Nieves Barragán Brun; Juan C Arboniés; Julia Bóveda Fontán; Remedios Martín Alvarez; Jose A Prados; Enrique Martín-Rioboó; Josep Massons; Margarita Criado; José Á Fernández; Juan M Parras; Roger Ruiz-Moral; Jesús M Novo Journal: BMC Fam Pract Date: 2012-11-22 Impact factor: 2.497